{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:10:28Z","timestamp":1759104628614,"version":"3.44.0"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81170133","81670333"],"award-info":[{"award-number":["81170133","81670333"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Pillar Program of Hubei Province, China","award":["2015BKA340"],"award-info":[{"award-number":["2015BKA340"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.ijcard.2018.02.089","type":"journal-article","created":{"date-parts":[[2018,6,6]],"date-time":"2018-06-06T04:56:45Z","timestamp":1528261005000},"page":"38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Ethyl pyruvate: A promising feasible therapeutic approach for myocardial ischemia-reperfusion injury under both normoglycemia and hyperglycemia"],"prefix":"10.1016","volume":"265","author":[{"given":"Qi","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Xing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2018.02.089_bb0005","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijcard.2017.11.038","article-title":"Ethyl pyruvate attenuates myocardial ischemia-reperfusion injury exacerbated by hyperglycemia via retained inhibitory effect on HMGB1","volume":"252","author":"Soh","year":"2018","journal-title":"Int. J. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcard.2018.02.089_bb0010","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3892\/etm.2015.2290","article-title":"Role of high-mobility group box-1 in myocardial ischemia\/reperfusion injury and the effect of ethyl pyruvate","volume":"9","author":"Lin","year":"2015","journal-title":"Exp. Ther. Med."},{"issue":"4","key":"10.1016\/j.ijcard.2018.02.089_bb0015","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.jtcvs.2017.10.069","article-title":"Ethyl pyruvate is renoprotective against ischemia-reperfusion injury under hyperglycemia","volume":"155","author":"Jun","year":"2018","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ijcard.2018.02.089_bb0020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2337\/db09-0801","article-title":"Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands","volume":"59","author":"Yao","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.ijcard.2018.02.089_bb0025","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.hlc.2004.12.021","article-title":"Ethyl pyruvate enhances ATP levels, reduces oxidative stress and preserves cardiac function in a rat model of off-pump coronary bypass","volume":"14","author":"Taylor","year":"2005","journal-title":"Heart Lung Circ."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318301396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318301396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:39:07Z","timestamp":1759091947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527318301396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":5,"alternative-id":["S0167527318301396"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.02.089","relation":{},"ISSN":["0167-5273"],"issn-type":[{"type":"print","value":"0167-5273"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ethyl pyruvate: A promising feasible therapeutic approach for myocardial ischemia-reperfusion injury under both normoglycemia and hyperglycemia","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.02.089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2017.11.038","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}